StockVS

Koninklijke Philips N.V. (PHG) स्टॉक विश्लेषण

स्वास्थ्य सेवा

Koninklijke Philips N.V.

$26.94

$-0.01 (-0.04%)

अंतिम अपडेट: 26 मई 2026

प्राइस हिस्ट्री

विश्लेषण

कंपनी का अवलोकन

Koninklijke Philips N.V. operates as a prominent health technology entity serving North America, Greater China, and international markets through its Diagnosis & Treatment, Connected Care, and Personal Health segments. The firm specializes in providing diagnostic imaging solutions, including a dedicated ultrasound business unit, while functioning within the broader Healthcare sector under the Medical Devices industry classification. This sector classification indicates that the company's performance is intrinsically linked to global healthcare spending trends, technological advancements in medical equipment, and regulatory standards governing medical device distribution. The company demonstrates a significant market presence with a market capitalization of $25.67B and reported annual revenue of $17.83B, supported by a workforce of 61,085 employees. These valuation and revenue figures suggest that Philips maintains a substantial operational scale and holds a considerable position within the competitive landscape of global medical technology providers, allowing it to invest heavily in research and development while managing complex supply chains.

वित्तीय स्वास्थ्य

The company reported a trailing twelve-month revenue of $17.83B, accompanied by a net income of $899.00M and an EBITDA of $2.02B, illustrating a substantial gap between top-line revenue and bottom-line profit that highlights a cost structure involving significant operating expenses, taxes, and interest costs. Free cash flow stands at $453.00M, which signifies the company's ability to generate cash after capital expenditures, thereby providing financial flexibility for debt servicing, share repurchases, or capital investments without relying on external financing. Profitability is analyzed through three key margins: a gross margin of 45.2%, an operating margin of 10.7%, and a profit margin of 5.0%, where the high gross margin reflects strong pricing power and cost control in manufacturing, while the lower operating and profit margins indicate substantial overhead burdens and tax impacts. Liquidity and leverage are assessed by comparing total cash of $2.79B against total debt of $8.09B, a disparity highlighted by a debt-to-equity ratio of 73.57, which suggests the balance sheet is leveraged rather than conservative. Short-term liquidity is supported by a current ratio of 1.32, indicating that current assets exceed current liabilities by a factor that allows for adequate coverage of immediate obligations. Management effectiveness is revealed through a return on equity of 7.8% and a return on assets of 3.2%, metrics that suggest the company generates moderate returns on shareholder capital and utilizes its asset base efficiently to produce profits.

मूल्यांकन आकलन

Valuation metrics for Koninklijke Philips N.V. include a trailing P/E ratio of 25.03 and a forward P/E of 12.84, where the significant difference between these figures implies that the market expects earnings to grow substantially in the future to justify the current price relative to anticipated future profits. The price-to-book ratio is 2.01, indicating that the stock trades at a premium over its book value, which often reflects investor confidence in the company's intangible assets, brand equity, and future growth potential beyond the tangible assets listed on the balance sheet. Alternative valuation perspectives are provided by a price-to-sales ratio of 1.44 and an EV/EBITDA of 15.28, which offer normalized views of value that account for the company's enterprise value and cash generation capabilities relative to its sales and earnings power. Price volatility over the past year is contextualized by a 52-week high of $33.44 and a 52-week low of $21.48, placing the current trading price approximately 26.7% below the 52-week high based on the distance from the current market level to the peak. Risk sensitivity is measured by a beta of 0.94, which indicates that the stock's price volatility moves slightly less than the broader market, suggesting a marginally lower systematic risk profile compared to the general equity market index.

Growth & Income

Growth dynamics are characterized by a revenue growth rate of 1.1% year-over-year, while earnings growth is marked as N/A, implying that current profitability levels may be stagnant or volatile relative to the modest expansion in sales volume. For dividend-paying entities like Philips, the stock offers a dividend yield of 3.8% with a payout ratio of 91.7%, a high ratio that requires close monitoring as it indicates the company is paying out the vast majority of its earnings, which may constrain future dividend growth if earnings do not accelerate significantly. The absence of reported earnings growth data suggests that management must navigate cost pressures to improve net income margins, as revenue alone is insufficient to drive proportional profit expansion. Overall, the company presents a profile defined by moderate revenue expansion, a generous current dividend yield, and a leverage-heavy capital structure that prioritizes shareholder returns through dividends rather than aggressive reinvestment for growth, balancing income generation with financial obligations.

समकक्ष तुलना

Koninklijke Philips N.V. (PHG) चिकित्सा उपकरण उद्योग में कार्यरत है। बाजार पूंजीकरण के आधार पर इसके निकटतम समकक्षों से तुलना इस प्रकार है:

कंपनी टिकर मार्केट कैप P/E अनुपात
Koninklijke Philips N.V. PHG $25.66B 23.2
Abbott Laboratories ABT $150.96B 24.3
Stryker Corporation SYK $119.99B 36.2
Medtronic plc MDT $99.63B 21.7

चिकित्सा उपकरण उद्योग का औसत P/E अनुपात 60.2x है। Koninklijke Philips N.V. का P/E अनुपात 23.2 है।

यह विश्लेषण AI द्वारा केवल सूचनात्मक उद्देश्यों के लिए तैयार किया गया है और यह वित्तीय सलाह नहीं है। डेटा में देरी या अशुद्धि हो सकती है। निवेश निर्णय लेने से पहले हमेशा अपना शोध करें और किसी योग्य वित्तीय सलाहकार से परामर्श लें।

Koninklijke Philips N.V. के बारे में

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

कंपनी विवरण अंग्रेजी में दिखाया गया है।

वेबसाइट देखें →

मुख्य आंकड़े

मार्केट कैप
$25.66B
P/E अनुपात
23.23
52 सप्ताह उच्च
$33.44
52 सप्ताह निम्न
$21.95
औसत वॉल्यूम
1.10M
बीटा
0.92
डिविडेंड यील्ड
3.76%

डेटा yfinance के माध्यम से Yahoo Finance द्वारा प्रदान किया गया है। दैनिक अपडेट।

कंपनी जानकारी

एक्सचेंज
NYSE
देश
Netherlands
कर्मचारी
64,317